The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome.
BACKGROUND
Previous studies of patients with postural tachycardia syndrome (POTS) have been hampered by relatively small cohorts, failure to control medications and diet, and inconsistent testing procedures.


METHODS
The Vanderbilt Autonomic Dysfunction Center Database provided results of posture studies performed in 165 patients and 66 normal controls after dietary and medication restrictions. All posture studies were performed after an overnight fast and > or =30 minutes of supine rest.


RESULTS
In both the supine and standing positions, heart rate (HR) and plasma concentrations of norepinephrine (NE), epinephrine, and dopamine were higher in patients with POTS compared with the healthy controls. Supine diastolic blood pressure (BP) was also elevated in POTS, whereas supine plasma l-3,4-dihydroxyphenyalanine was reduced. In an analysis of patient subgroups with either an upright plasma NE > or = 3.54 nM (high NE) or an upright plasma NE < 3.54 nM (normal NE), HR and BP were greater in the patient subgroup with high NE. In addition to these significant differences in hemodynamic and catechol measurements, we demonstrated that supine and standing plasma aldosterone and the aldosterone/renin ratio were decreased in patients with POTS. Plasma renin activity (PRA) tended to be higher in patients, and standing HR for those in the highest PRA quartile was significantly greater than for those in the lowest PRA quartile.


CONCLUSIONS
Our results from larger cohorts of patients and controls than previously studied confirm published findings and contribute additional evidence of sympathetic activation in postural tachycardia syndrome (POTS). Abnormalities in the renin-angiotensin-aldosterone system may also contribute to the POTS phenotype.
Garland
E M
EM
Autonomic Dysfunction Center, Vanderbilt University, Nashville, TN 37232-2195, USA. emily.garland@vanderbilt.edu
Raj
S R
SR
Black
B K
BK
Harris
P A
PA
Robertson
D
D
D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000097:blood*; D001342:Autonomic Nervous System Diseases / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D002395:Catecholamines / Q000097:blood*; D002560:Cerebrovascular Circulation / Q000502:physiology; D015331:Cohort Studies; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009490:Neurosecretory Systems / Q000503:physiopathology; D010641:Phenotype; D011187:Posture / Q000502:physiology; D011446:Prospective Studies; D012083:Renin / Q000097:blood*; D013564:Sympathetic Nervous System / Q000503:physiopathology; D013575:Syncope / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D013610:Tachycardia / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D014882:Water-Electrolyte Balance / Q000502:physiology
D015415:Biomarkers; D002395:Catecholamines; D000450:Aldosterone; D012083:Renin